Get a refill — $59
Home › Blog › Ozempic and Mounjaro Refills at Your Current Dose

Ozempic and Mounjaro Refills at Your Current Dose — No Titration, No New Starts

Quick answer: Dr. Refills can electronically refill FDA-approved GLP-1 and GIP agonists — including Ozempic, Mounjaro, Wegovy, Zepbound, Trulicity, Victoza, Saxenda, and Rybelsus — for patients who are already established on a stable dose and simply cannot get a timely appointment. This is same-dose continuation only: no new starts, no dose changes, no titration. The flat fee is $59 for a 30-day supply (or $79 for 90 days), charged only if approved, with the prescription sent electronically to your pharmacy — typically within one hour.

Already Stable on a GLP-1? Request Your Refill Now

If you've been on the same dose of Ozempic, Mounjaro, Wegovy, Zepbound, Trulicity, Victoza, Saxenda, or Rybelsus for at least 3 months and just need a continuation refill, a board-certified MD can review your request — often within the hour. $59 flat, only charged if approved.

Start my refill →

What Is This Service, and Who Is It For?

If you have been taking a GLP-1 receptor agonist or GIP/GLP-1 dual agonist for at least three months at the same dose, and your prescribing physician is unavailable, on leave, or simply has no appointment slots for weeks, you may be facing an unwanted gap in your medication. A gap in therapy is not a minor inconvenience — it can disrupt the management of your type 2 diabetes or other condition your prescriber placed you on this medication to treat.

Dr. Refills is an asynchronous telehealth service that allows a board-certified internist to review your information, confirm that continuation is appropriate, and send a refill electronically to your own pharmacy — without requiring you to come in for an in-person visit or wait for a telehealth video slot to open up. You submit your information, the physician reviews it, and if approved, the prescription goes to your pharmacy. That is the entire service.

This service is continuation only. It exists for patients who are already established on a medication, at a stable dose, and need a bridge refill while they arrange ongoing care with their regular provider.

Which Medications Can Be Refilled Through This Service?

Dr. Refills can review requests for same-dose continuation of the following FDA-approved injectable and oral GLP-1 or GIP agonist medications:

Important: Only brand-name, FDA-approved formulations sent to a licensed pharmacy are within scope. Compounded semaglutide, compounded tirzepatide, peptide blends, or any product not approved and commercially distributed by the brand manufacturer cannot be refilled through this service.

What This Service Will NOT Do — Please Read This Section Carefully

Being clear about scope is not fine print — it is the most important thing to understand before you submit a request. Dr. Refills will not, under any circumstances:

The single, narrow purpose of this service is to bridge a gap for a patient who is already stable and simply cannot reach their regular prescriber in time.

What Is the Minimum Eligibility Requirement?

To be eligible for a same-dose continuation refill through Dr. Refills, you must have been on the same dose of the same medication for a minimum of three consecutive months. This is not an arbitrary threshold. Three months of stability at a given dose means:

Patients who are mid-titration — for example, someone who has been on 0.5 mg semaglutide for four weeks and is due to step up — are not eligible. Titration decisions belong with your established prescriber.

What Are the Disqualifying Conditions and Routes to Physician Review?

Even for an established patient requesting a continuation refill, certain medical histories or current symptoms require that you return to your prescribing physician rather than use an asynchronous telehealth refill service. The physician reviewing your request through Dr. Refills will not approve a refill if any of the following apply:

Condition or Symptom Why It Matters What to Do
Severe or persistent gastrointestinal symptoms (nausea, vomiting, abdominal pain, inability to tolerate oral intake) May indicate pancreatitis, gastroparesis exacerbation, or a serious GI event requiring evaluation See your physician or, if severe, go to an emergency department
History of pancreatitis (acute or chronic) GLP-1 agonists carry labeling warnings regarding pancreatitis risk; this requires individualized prescriber judgment Discuss with your established prescriber
History of gallbladder disease or cholelithiasis Increased rates of gallbladder-related events are noted in labeling for some agents in this class; ongoing monitoring belongs with your physician Discuss with your established prescriber
Personal or family history of medullary thyroid carcinoma (MTC) GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors; this is an absolute contraindication in labeling Do not use this service; consult your prescriber
Personal or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Same boxed warning applies; contraindicated per labeling Do not use this service; consult your prescriber
Current pregnancy or suspicion of pregnancy Use in pregnancy requires individualized physician evaluation and is not appropriate for asynchronous refill Contact your OB or prescribing physician promptly

If you are experiencing a medical emergency — including severe abdominal pain, chest pain, difficulty breathing, or signs of a serious allergic reaction — call 911 or go to your nearest emergency department immediately. Do not use this or any online service in an emergency.

How Is This Different From Compounded-Peptide Sellers and "Weight Loss Program" Telehealth?

This is an important distinction, and patients deserve a straight answer. Over the past several years, a large number of websites and apps have emerged offering compounded semaglutide or compounded tirzepatide, often framed as weight-loss programs with built-in prescribing. That is a fundamentally different category of service.

Here is how Dr. Refills differs:

Feature Dr. Refills Compounded-Peptide / Weight-Loss Programs
Medication type FDA-approved brand formulations only (Ozempic, Mounjaro, etc.) Often compounded semaglutide or tirzepatide from 503A/B compounders
New starts Not offered Core business model
Titration management Not offered Often included
Pharmacy Patient's own licensed retail pharmacy Often a mail-order compounder
Scope Same-dose continuation only, minimum 3 months established Typically initiation and ongoing program management
Physician review Every request reviewed by Iwan S. Nyotowidjojo, MD, ABIM board-certified internist Varies widely by platform
Fee model $59 (30-day) or $79 (90-day), charged only if approved Varies; often subscription or program fees

If you have been prescribed an FDA-approved GLP-1 or GIP agonist by a physician and need a bridge refill at your current dose, Dr. Refills is built for that specific situation. If you are looking to start a new medication, explore compounded alternatives, or enter a supervised weight-management program, this service is not the right fit — and we would rather tell you that directly.

Who Reviews My Request?

Every single refill request submitted through Dr. Refills is reviewed individually by Iwan S. Nyotowidjojo, MD, a physician board-certified in Internal Medicine by the American Board of Internal Medicine (ABIM). Dr. Nyotowidjojo is personally licensed in each state where Dr. Refills operates. There are no mid-level providers making approval decisions on GLP-1 refill requests. You can review physician licensure information at drrefills.com/licensure.

Which States Does Dr. Refills Serve?

Dr. Refills currently operates in the following states:

You must be physically located in one of these states at the time you submit your request. Your prescription will be sent electronically to any licensed pharmacy in your state.

What Does It Cost, and How Does Payment Work?

The fee structure is straightforward:

The fee covers the physician review, not the cost of the medication itself. Your GLP-1 medication cost will be determined by your pharmacy and your insurance or discount program, exactly as it would be with any other prescription.

How Does the Process Work?

  1. Submit your request through the secure intake form at drrefills.com/maya. You will be asked about your current medication, dose, how long you have been on it, your prescribing history, and relevant medical history including the conditions listed above.
  2. Physician review — Dr. Nyotowidjojo reviews your submission. This is an asynchronous review, meaning you do not need to be available for a live video call.
  3. Approval or declination — If your request meets the eligibility criteria, the prescription is approved and sent electronically to your pharmacy. If it does not meet criteria, you are not charged and you will receive a note indicating that you should follow up with your established prescriber.
  4. Prescription at your pharmacy — Approved prescriptions are typically transmitted within one hour during review hours.

Need a Refill of

Related reading